RecruitingNCT06724029

Neurosurgical Outcome Network

Neurosurgical Outcome Network Per la Predizione Dell'Outcome in Neurochirurgia

Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Enrollment

4,500 participants

Start Date

Dec 5, 2022

Study Type

OBSERVATIONAL

Conditions

Trigeminal Neuralgia Hydrocephalus Subarachnoid Hemorrhage Aneurysms Arteriovenous Malformations Cavernomas Skull Base Tumors Moyamoya Disease Dural Fistulas Subdural Hematoma Extradural Hematoma Spasticity Craniofacial Pain Neuropathic Pain Tremor Parkinson&Amp;#39;s Disease Dystonias

Summary

The evaluation of neurosurgical outcomes varies from center to center, and the predictive factors that determine these outcomes are not fully known or shared. This study aims to assess outcomes and their predictors using measures agreed upon by the participating centers. Standardizing the evaluation of outcomes and predictors improves the quality of research, allows for data comparison, and facilitates a "common language" in routine clinical practice. Most importantly, it influences therapeutic decisions in various neurosurgical conditions. Clinically, the identified predictors can also be used during preoperative assessments to provide more precise guidance to patients undergoing surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational registry study that collects data on brain tumor surgeries and skull-base procedures to better understand outcomes and improve neurosurgical care. **You may be eligible if...** - You have a brain or skull-base tumor requiring surgery (including tumors in the frontal, middle, or posterior skull base, pituitary region, or inside and outside brain tissue) - You are being treated at a participating neurosurgery center **You may NOT be eligible if...** - You decline to have your surgical data recorded in the registry - You do not have a neurosurgical condition covered by the study protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(27)

1. ASST Papa Giovanni XXIII

Bergamo, BG, Italy

Spedali Civili Brescia

Brescia, BS, Italy

Fondazione Poliambulanza Istituto Ospedaliero

Brescia, BS, Italy

Ospedale Moriggia Pelascini

Gravedona, Como, Italy

ASST Lariana, Ospedale S. Anna

Como, CO, Italy

ASST Cremona

Cremona, CR, Italy

Fondazione IRCCS San Gerardo dei Tintori

Monza, MB, Italy

Fondazione IRCCS Policlinico San Matteo

Pavia, PV, Italy

ASST della Valtellina ed Alto Lario

Sondrio, SO, Italy

Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco"

Catania, Italy

Azienda Ospedaliero Universitaria Careggi

Florence, Italy

Ospedale F. Spaziani di Frosinone

Frosinone, Italy

Ospedale Alessandro Manzoni

Lecco, Italy

ASST Ovest Milanese

Legnano, Italy

Ospedali Riuniti di Livorno -Azienda USL Toscana nord ovest

Livorno, Italy

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Milan, Italy

ASST Santi Paolo e Carlo

Milan, Italy

ASST Fatebenefratelli Sacco

Milan, Italy

Istituto Clinico Città Studi

Milan, Italy

Policlinico di Monza

Monza, Italy

A.R.N.A.S. Ospedali Civico di Palermo

Palermo, Italy

Azienda Ospedaliero Universitaria di Parma

Parma, Italy

ASL Roma 1

Roma, Italy

Fondazione Policlinico Universitario Gemelli di Roma

Roma, Italy

IRCCS Istituto Clinico Humanitas

Rozzano, Italy

Azienda Sanitaria Universitaria Friuli Centrale di Udine

Udine, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06724029

Related Trials

European Study of Prodromal iNPH

NCT059109447 locations

Pilot Study on Muscle, Tendon, and Neural Changes Post-Botulinum Toxin Injections in Post-stroke Spastic Equinovarus

NCT067676311 location

Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage

NCT040435983 locations

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

NCT049308871 location

Remimazolam Consumption: TCI vs. Manual Infusion

NCT073776951 location